South Africa and India, backed by many emerging nations, want a temporary waiver of IP rights on vaccines and other treatments to allow local manufacturers to produce shots.
Aforikaborwa le India, ba tshegeditswe ke dinaga di le dintsi tse di santseng di gola, ba batla tlogelo ya nakwana ya ditshwanelo tsa IP tsa meento le dikalafi tse dingwe go letla badiri ba selegae go dira meento.